245 related articles for article (PubMed ID: 23631918)
1. Clostridium difficile binary toxin CDT induces clustering of the lipolysis-stimulated lipoprotein receptor into lipid rafts.
Papatheodorou P; Hornuss D; Nölke T; Hemmasi S; Castonguay J; Picchianti M; Aktories K
mBio; 2013 Apr; 4(3):e00244-13. PubMed ID: 23631918
[TBL] [Abstract][Full Text] [Related]
2. Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).
Hemmasi S; Czulkies BA; Schorch B; Veit A; Aktories K; Papatheodorou P
J Biol Chem; 2015 May; 290(22):14031-44. PubMed ID: 25882847
[TBL] [Abstract][Full Text] [Related]
3. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.
Kaiser E; Kroll C; Ernst K; Schwan C; Popoff M; Fischer G; Buchner J; Aktories K; Barth H
Infect Immun; 2011 Oct; 79(10):3913-21. PubMed ID: 21768281
[TBL] [Abstract][Full Text] [Related]
4. Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT).
Papatheodorou P; Carette JE; Bell GW; Schwan C; Guttenberg G; Brummelkamp TR; Aktories K
Proc Natl Acad Sci U S A; 2011 Sep; 108(39):16422-7. PubMed ID: 21930894
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb.
Landenberger M; Nieland J; Roeder M; Nørgaard K; Papatheodorou P; Ernst K; Barth H
Biochim Biophys Acta Biomembr; 2021 Jun; 1863(6):183603. PubMed ID: 33689753
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.
Gerding DN; Johnson S; Rupnik M; Aktories K
Gut Microbes; 2014; 5(1):15-27. PubMed ID: 24253566
[TBL] [Abstract][Full Text] [Related]
7. Identification of the cellular receptor of Clostridium spiroforme toxin.
Papatheodorou P; Wilczek C; Nölke T; Guttenberg G; Hornuss D; Schwan C; Aktories K
Infect Immun; 2012 Apr; 80(4):1418-23. PubMed ID: 22252869
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria.
Schwan C; Stecher B; Tzivelekidis T; van Ham M; Rohde M; Hardt WD; Wehland J; Aktories K
PLoS Pathog; 2009 Oct; 5(10):e1000626. PubMed ID: 19834554
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis for Binding of Neutralizing Antibodies to
Goldsmith JA; Dewar V; Hermand P; Blais N; McLellan JS
J Bacteriol; 2023 Apr; 205(4):e0045622. PubMed ID: 36951574
[TBL] [Abstract][Full Text] [Related]
10. Interaction of
Nagahama M; Takehara M; Kobayashi K
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30297616
[TBL] [Abstract][Full Text] [Related]
11. Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT.
Roeder M; Nestorovich EM; Karginov VA; Schwan C; Aktories K; Barth H
Toxins (Basel); 2014 Jul; 6(7):2097-114. PubMed ID: 25029374
[TBL] [Abstract][Full Text] [Related]
12. Binary Clostridium difficile toxin (CDT) - A virulence factor disturbing the cytoskeleton.
Aktories K; Papatheodorou P; Schwan C
Anaerobe; 2018 Oct; 53():21-29. PubMed ID: 29524654
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol- and sphingolipid-rich microdomains are essential for microtubule-based membrane protrusions induced by Clostridium difficile transferase (CDT).
Schwan C; Nölke T; Kruppke AS; Schubert DM; Lang AE; Aktories K
J Biol Chem; 2011 Aug; 286(33):29356-29365. PubMed ID: 21705797
[TBL] [Abstract][Full Text] [Related]
14. Structure of the cell-binding component of the
Xu X; Godoy-Ruiz R; Adipietro KA; Peralta C; Ben-Hail D; Varney KM; Cook ME; Roth BM; Wilder PT; Cleveland T; Grishaev A; Neu HM; Michel SLJ; Yu W; Beckett D; Rustandi RR; Lancaster C; Loughney JW; Kristopeit A; Christanti S; Olson JW; MacKerell AD; Georges AD; Pozharski E; Weber DJ
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1049-1058. PubMed ID: 31896582
[TBL] [Abstract][Full Text] [Related]
15. EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin.
Schnell L; Mittler AK; Sadi M; Popoff MR; Schwan C; Aktories K; Mattarei A; Azarnia Tehran D; Montecucco C; Barth H
Toxins (Basel); 2016 Apr; 8(4):101. PubMed ID: 27043629
[TBL] [Abstract][Full Text] [Related]
16. (1)H(N), (13)C, and (15)N resonance assignments of the CDTb-interacting domain (CDTaBID) from the Clostridium difficile binary toxin catalytic component (CDTa, residues 1-221).
Roth BM; Varney KM; Rustandi RR; Weber DJ
Biomol NMR Assign; 2016 Oct; 10(2):335-9. PubMed ID: 27351891
[TBL] [Abstract][Full Text] [Related]
17. Characterization and Pharmacological Inhibition of the Pore-Forming
Ernst K; Landenberger M; Nieland J; Nørgaard K; Frick M; Fois G; Benz R; Barth H
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34071730
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the transition of Clostridioides difficile binary toxin from prepore to pore.
Anderson DM; Sheedlo MJ; Jensen JL; Lacy DB
Nat Microbiol; 2020 Jan; 5(1):102-107. PubMed ID: 31712627
[TBL] [Abstract][Full Text] [Related]
19. The Importance of Therapeutically Targeting the Binary Toxin from
Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.
Gülke I; Pfeifer G; Liese J; Fritz M; Hofmann F; Aktories K; Barth H
Infect Immun; 2001 Oct; 69(10):6004-11. PubMed ID: 11553537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
